The Influence of Low Oxygen on Macrophage Response to Leishmania Infection

Scandinavian Journal of Immunology

Volumn 74, Issue 2, 2011, Pages 165-175

  Degrossoli, A ^a   Arrais Silva, W W ^a   Colhone, M C ^a   Gadelha, F R ^a   Joazeiro, P P ^a   Giorgio, S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; EBSELEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; NITRIC OXIDE; OXYGEN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

AMASTIGOTE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL HYPOXIA; CYTOKINE PRODUCTION; DNA FRAGMENTATION; EXOCYTOSIS; FEMALE; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; MICROBIAL ACTIVITY; MICROENVIRONMENT; MOUSE; NONHUMAN; PARASITE CONTROL; PARASITISM; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLCYSTEINE; ANIMALS; ANOXIA; AZOLES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; FEMALE; FREE RADICAL SCAVENGERS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERLEUKIN-10; INTERLEUKIN-12; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; ORGANOSELENIUM COMPOUNDS; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79960086262     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2011.02566.x     Document Type: Article

References (50)

1. Blouw B, Song H, Tihan T et al. The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell 2003;4:133-46.
2. Ikeda E. Cellular response to tissue hypoxia and its involvement in disease progression. Pathol Int 2005;55:603-10.
3. Lewis JS, Lee JA, Underwood JC, Harris AL, Lewis CE. Macrophage responses to hypoxia: relevance to disease mechanisms. J Leukoc Biol 1999;66:889-900.
4. Murdoch C, Muthana M, Lewis CE. Hypoxia regulates macrophage functions in inflammation. J Immunol 2005;175:6257-63.
5. Nizet V, Johnson RS. Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 2009;9:609-17.
6. Zinkernagel AS, Johnson RS, Nizet V. Hypoxia inducible factor (HIF) function in innate immunity and infection. J Mol Med 2007;85:1339-46.
7. Colhone MC, Arrais-Silva WW, Picoli C, Giorgio S. Effect of hypoxia on macrophage infection by Leishmania amazonensis. J Parasitol 2004;90:510-5.
8. Degrossoli A, Colhone MC, Arrais-Silva WW, Giorgio S. Hypoxia modulates expression of the 70-kD heat shock protein and reduces Leishmania infection in macrophages. J Biomed Sci 2004;11:847-54.
9. Degrossoli A, Giorgio S. Functional alterations in macrophages after hypoxia selection. Exp Biol Med (Maywood) 2007;232:88-95.
10. Degrossoli A, Bosetto MC, Lima CB, Giorgio S. Expression of hypoxia-inducible factor 1alpha in mononuclear phagocytes infected with Leishmania amazonensis. Immunol Lett 2007;114:119-25.
11. Arrais-Silva WW, Paffaro VA Jr, Yamada AT, Giorgio S. Expression of hypoxia-inducible factor-1alpha in the cutaneous lesions of BALB/c mice infected with Leishmania amazonensis. Exp Mol Pathol 2005;78:49-54.
12. Grimaldi G Jr, Tesh RB. Leishmaniases of the New World: current concepts and implications for future research. Clin Microbiol Rev 1993;6:230-50.
13. Nylén S, Gautam S. Immunological perspectives of leishmaniasis. J Glob Infect Dis 2010;2:135-46.
14. Barbieri CL, Giorgio S, Merjan AJ, Figueiredo EN. Glycosphingolipid antigens of Leishmania (Leishmania) amazonensis amastigotes identified by use of a monoclonal antibody. Infect Immun 1993;61:2131-7.
15. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
16. Puerto M, Guayerbas N, Víctor V, De la Fuente M. Effects of N-acetylcysteine on macrophage and lymphocyte functions in a mouse model of premature ageing. Pharmacol Biochem Behav 2002;73:797-804.
17. Dickinson DA, Moellering DR, Iles KE et al. Cytoprotection against oxidative stress and the regulation of glutathione synthesis. Biol Chem 2003;384:527-37.
18. Yang CF, Shen HM, Ong CN. Protective effect of ebselen against hydrogen peroxide-induced cytotoxicity and DNA damage in HepG2 cells. Biochem Pharmacol 1999;57:273-9.
19. Holmgren A. Antioxidant function of thioredoxin and glutaredoxin systems. Antioxid Redox Signal 2000;2:811-20.
20. Chaudhuri G, Chauduri M, Pan A, Chang K-P. Surface Acid Proteinase (gp63) of Leishmania mexicana a metalloenzyme capable of protecting liposome-encapsulated proteins from phagolysosomal degradation by macrophages. J Biol Chem 1989;264:7483-9.
21. Rodrigues JCF, Concepcion JL, Rodrigues C, Caldera A, Urbina JA, Souza W. In vitro activities of ER-119884 and E5700, two potent squalene synthase inhibitors, against Leishmania amazonensis: antiproliferative, biochemical, and ultrastructural effects. Antimicrob Agents Chemother 2008;2:4098-114.
22. Dantas AP, Barbosa HS, de Castro SL. Biological and ultrastructural effetcs of the anti-microtubule agent taxol against Trypanosoma cruzi. J Submicrosc Cytol Pathol 2003;35:287-94.
23. Linares E, Giorgio S, Augusto O. Inhibition of in vivo leishmanicidal mechanisms by tempol: nitric oxide down-regulation and oxidant scavenging. Free Radic Biol Med 2008;44:1668-76.
24. Stafford JL, Neumann NF, Belosevic M. Macrophage-mediated innate host defense against protozoan parasites. Crit Rev Microbiol 2002;28:187-248.
25. Bisti S, Konidou G, Boelaert J, Lebastard M, Soteriadou K. The prevention of the growth of Leishmania major progeny in BALB/c iron-loaded mice: a process coupled to increased oxidative burst, the amplitude and duration of which depend on initial parasite developmental stage and dose. Microbes Infect 2006;8:1464-72.
26. Murray HW. Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages. J Exp Med 1981;153:1302-15.
27. Schroder K, Hertzog PJ, Ravasi Y, Hume DA. Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 2004;75:163-89.
28. Leeper-Woodford SK, Mills JW. Phagocytosis and ATP levels in alveolar macrophages during acute hypoxia. Am J Respir Cell Mol Biol 1992;6:326-34.
29. Holzmuller P, Sereno D, Cavaleyra M et al. Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes. Infect Immun 2002;70:3727-35.
30. Bosco MC, Puppo M, Blengio F et al. Monocytes and dendritic cells in a hypoxic environment: spotlights on chemotaxis and migration. Immunobiology 2008;213:733-49.
31. Gantt KR, Goldman TL, McCormick ML et al. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J Immunol 2001;167:893-901.
32. Bhogal RH, Curbishley SM, Weston CJ, Adams DH, Afford SC. Reactive oxygen species mediate human hepatocyte injury during hypoxia/reoxygenation. Liver Transpl 2010;16:1303-13.
33. Ogunrinu TA, Sontheimer H. Hypoxia increases the dependence of glioma cells on glutathione. J Biol Chem 2010;285:37716-24.
34. Yu BP. Cellular defenses against damage from reactive oxygen species. Physiol Rev 1994;74:139-62.
35. Kietzmann T, Gorlach A. Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin Cell Dev Biol 2005;16:474-86.
36. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006;8:S3-8.
37. Rattigan Y, Hsu JM, Mishra PJ, Glod J, Banerjee D. Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu. Exp Cell Res 2010;316:3417-24.
38. Hatzigeorgiou DE, He S, Sobel J, Grabstein KH, Hafner A, Ho JL. IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages. J Immunol 1993;151:3682-92.
39. Leeper-Woodford SK, Detmer K. Acute hypoxia increases alveolar macrophage tumor necrosis factor activity and alters NF-kappaB expression. Am J Physiol 1999;276:L909-16.
40. Reichner JS, Fitzpatrick PA, Wakshull E, Albina JE. Receptor-mediated phagocytosis of rat macrophages is regulated differentially for opsonized particles and non-opsonized particles containing beta-glucan. Immunology 2001;104:198-206.
41. Wyler DJ. In vitro parasite-monocyte interactions in human leishmaniasis. Evidence for an active role of the parasite in attachment. J Clin Invest 1982;70:82-8.
42. Kawaguchi T, Veech RL, Uyeda K. Regulation of energy metabolism in macrophages during hypoxia. Roles of fructose 2, 6-bisphosphate and ribose 1, 5-bisphosphate. J Biol Chem 2001;276:28554-61.
43. Leppänen O, Björnheden T, Evaldsson M, Borén J, Wiklund O, Levin M. ATP depletion in macrophages in the core of advanced rabbit atherosclerotic plaques in vivo. Atherosclerosis 2006;188:323-30.
44. Vijayasarathy C, Damle S, Prabu SK, Otto CM, Avadhani NG. Adaptive changes in the expression of nuclear and mitochondrial encoded subunits of cytochrome c oxidase and the catalytic activity during hypoxia. Eur J Biochem 2003;270:871-9.
45. Verma NK, Dey CS. Possible mechanism of miltefosine-mediated death of Leishmania donovani. Antimicrob Agents Chemother 2004;48:3010-5.
46. 2+ through non-selective cation channels in the host and the parasite is responsible for apoptosis of intracellular Leishmania donovani amastigotes. J Biol Chem 2003;278:25120-32.
47. Werth N, Beerlage C, Rosenberger C et al. Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS ONE 2010;5:e11576.
48. Patel SA, Simon MC. Biology of hypoxia-inducible factor 2α in the development and disease. Cell Death Differ 2008;15:628-34.
49. Loboda A, Jozkowicz A, Dulak J. HIF-1 and HIF-2 transcription factors- similar but not identical. Mol Cells 2010;29:435-42.
50. Spear W, Chan D, Coppens I, Johnson RS, Giaccia A, Blader IJ. The host cell transcription factor hypoxia-inducible factor 1 is required for Toxoplasma gondii growth and survival at physiological oxygen levels. Cell Microbiol 2006;8:339-52.